A new study just published on Feb 2011 in the journal of cancer makes a strong argument for applying hyperbaric oxygenation therapy (HBOT) for those patients who have had either surgery or radiation therapy for brain tumors. The study followed patients who had been treated with HBOT and there was a marked improvement in cognitive function which was supported and documented by standard neuropsychological testing <view study> Read Less

Virgina Mason Hospital’s hyperbaric unit has pulled together a report which documents 411 of their patients who took course in HBOT following radiation therapy, for the diagnosis of chronic radiation-induced tissue damage. The results were quite dramatic. For example, a positive outcome from hyperbaric treatment occurred in 94% of patients with osteoradionecrosis of the jaw. Hopefully, this will encourage the medical community to make stronger recommendations for hyperbaric therapy <view study> Read Less

Temozolomide is currently being used for aggressive brain tumors, among other cancers. The effectiveness of this treatment is reduced with tumor hypoxia (low oxygen levels). Hyperbaric oxygen therapy was shown in this study to reduce tumor hypoxia and thus help to increase the effectiveness of Temozolomide against the glioma, producing a much more powerful anti-tumor activity. This research is consistent with many recent studies showing the added effectiveness of hyperbaric oxygen therapy with conventional therapies like chemotherapy, in helping to increase the effectiveness of these therapies <view study> Read Less

“Idiopathic sudden sensorineural hearing loss (ISSHL) is the newest indication approved by the Undersea and Hyperbaric Medical Society’s Hyperbaric Oxygen Therapy Committee” Sound research combined with clinical efficacy has bolstered the use of hyperbaric oxygen therapy for this condition. It gives us new hope in the hyperbaric industry that more conditions can follow and get recognized for the many indications that have been shown in recent literature, combined with the results seen in many of the private hyperbaric centers throughout the world <view study> Read Less

Currently, hyperbaric oxygen therapy is a valuable hospital tool for diabetics with chronic non-healing wounds and is a therapy that is reserved for late stages of diabetics. With recent literature supporting the use of HBOT for earlier onset, this new study gives us further hope that hyperbaric oxygen should be used for early stage diabetes and not just reserved for later stages. Here, it was shown that obese, diabetic rats given HBOT enhanced glucose and lipid metabolism in the skeletal muscle. Since obesity runs rampant in the diabetic population, and the concomitant effects of blood sugar elevation damaging the small blood vessels of the body, HBOT may prove as a valuable resource for diabetics, not only for its aid in cardiovascular disease and wound healing support, but for also lowering the levels of blood sugar; thereby, causing less damage in the body <view study> Read Less